Business
Healius braces for COVID test surge as restrictions lift – Sydney Morning Herald
The boss of the pathology operator says PCR tests will become even more critical as borders reopen and new drugs for COVID hit…
Pathology provider Healius is ramping up investments in new equipment to speed up COVID-19 test results as the company prepares for the rush to test travellers when borders reopen.
Chief executive Malcolm Parmenter said the company, which is currently processing…
Continue Reading
-
Business19 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News19 hours agoDid AI write your accounting expert’s report? – Proctor
-
Business22 hours agoThis ASX All Ords stock has more than doubled investor’s money since January. Here’s why it’s tipped to surge another 45%!
-
Business20 hours agoBroker names 2 small cap ASX shares to buy for big returns